Compendium of Cancer Genome Aberrations

STBT5:Volunteer Assignments and Opportunities: Difference between revisions

[checked revision][checked revision]
← Older edit
VisualWikitext
No edit summary
No edit summary
 
(16 intermediate revisions by 2 users not shown)
Line 229: Line 229:
|9/21/2025
|9/21/2025
|12/21/2025
|12/21/2025
|PENDING
|COMPLETE
|
|12/8/2025
|
|Katie Schieffer
|
|12/8/2025
|
|Minimal genetic content added
|-
|-
|[[STBT5:Myositis_ossificans_and_fibro-osseous_pseudotumour_of_digits|Myositis ossificans and fibro-osseous pseudotumour of digits]]
|[[STBT5:Myositis_ossificans_and_fibro-osseous_pseudotumour_of_digits|Myositis ossificans and fibro-osseous pseudotumour of digits]]
Line 423: Line 423:
|9/21/2025
|9/21/2025
|12/21/2025
|12/21/2025
|PENDING
|COMPLETE
|
|12/8/2025
|
|Katie Schieffer
|
|12/8/2025
|
|No genetic association
|-
|-
|[[STBT5:Acral_fibromyxoma|Acral fibromyxoma]]
|[[STBT5:Acral_fibromyxoma|Acral fibromyxoma]]
Line 453: Line 453:
|[[STBT5:Palmar_fibromatosis_and_plantar_fibromatosis|Palmar fibromatosis and plantar fibromatosis]]
|[[STBT5:Palmar_fibromatosis_and_plantar_fibromatosis|Palmar fibromatosis and plantar fibromatosis]]
|Disease
|Disease
|Kate Schieffer
|Kati
e Schieffer
|9/21/2025
|9/21/2025
|12/21/2025
|12/21/2025
|PENDING
|COMPLETE
|
|12/12/2025
|
|Katie Schieffer
|
|12/12/2025
|
|Minimal genetic content added
|-
|-
|[[STBT5:Desmoid_fibromatosis|Desmoid fibromatosis]]
|[[STBT5:Desmoid_fibromatosis|Desmoid fibromatosis]]
Line 521: Line 522:
|9/24/2025
|9/24/2025
|12/24/2025
|12/24/2025
|PENDING
|COMPLETE
|
|12/18/2025
|
|Katie Schieffer
|
|12/18/2025
|
|
|-
|-
Line 543: Line 544:
|9/21/2025
|9/21/2025
|12/21/2025
|12/21/2025
|PENDING
|COMPLETE
|
|12/10/2025
|
|Katie Schieffer
|
|12/10/2025
|
|No genetic association
|-
|-
|[[STBT5:Superficial_CD34-positive_fibroblastic_tumour|Superficial CD34-positive fibroblastic tumour]]
|[[STBT5:Superficial_CD34-positive_fibroblastic_tumour|Superficial CD34-positive fibroblastic tumour]]
Line 562: Line 563:
|[[STBT5:Myxoinflammatory_fibroblastic_sarcoma|Myxoinflammatory fibroblastic sarcoma]]
|[[STBT5:Myxoinflammatory_fibroblastic_sarcoma|Myxoinflammatory fibroblastic sarcoma]]
|Disease
|Disease
|
|Mokhtar Abdelhammed, MD (trainee);
|
Katie Schieffer (mentor)
|
|3/1/2026
|
|6/30/2026
|PENDING
|
|
|
|
Line 662: Line 664:
|9/21/2025
|9/21/2025
|12/21/2025
|12/21/2025
|PENDING
|COMPLETE
|
|12/8/2025
|
|Katie Schieffer
|
|12/8/2025
|
|No genetic association
|-
|-
|[[STBT5:Giant_cell_tumour_of_soft_tissue|Giant cell tumour of soft tissue]]
|[[STBT5:Giant_cell_tumour_of_soft_tissue|Giant cell tumour of soft tissue]]
Line 673: Line 675:
|9/21/2025
|9/21/2025
|12/21/2025
|12/21/2025
|PENDING
|COMPLETE
|
|12/10/2025
|
|Katie Schieffer
|
|12/10/2025
|
|No genetic association
|-
|-
|[[STBT5:Synovial_haemangioma|Synovial haemangioma]]
|[[STBT5:Synovial_haemangioma|Synovial haemangioma]]
|Disease
|Disease
Line 695: Line 697:
|9/21/2025
|9/21/2025
|12/21/2025
|12/21/2025
|PENDING
|COMPLETE
|
|12/10/2025
|
|Katie Schieffer
|
|12/10/2025
|
|No genetic association
|-
|-
|[[STBT5:Arteriovenous_malformation/haemangioma|Arteriovenous malformation/haemangioma]]
|[[STBT5:Arteriovenous_malformation/haemangioma|Arteriovenous malformation/haemangioma]]
Line 717: Line 719:
|9/21/2025
|9/21/2025
|12/21/2025
|12/21/2025
|PENDING
|COMPLETE
|
|12/10/2025
|
|Katie Schieffer
|
|12/10/2025
|
|No genetic association
|-
|-
|[[STBT5:Anastomosing_haemangioma|Anastomosing haemangioma]]
|[[STBT5:Anastomosing_haemangioma|Anastomosing haemangioma]]
Line 781: Line 783:
|9/21/2025
|9/21/2025
|12/21/2025
|12/21/2025
|PENDING
|COMPLETE
|
|12/11/2025
|
|Katie Schieffer
|
|12/11/2025
|
|Minimal genetic content added
|-
|-
|[[STBT5:Papillary_intralymphatic_angioendothelioma|Papillary intralymphatic angioendothelioma]]
|[[STBT5:Papillary_intralymphatic_angioendothelioma|Papillary intralymphatic angioendothelioma]]
Line 792: Line 794:
|9/21/2025
|9/21/2025
|12/21/2025
|12/21/2025
|PENDING
|COMPLETE
|
|12/11/2025
|
|Katie Schieffer
|
|12/11/2025
|
|Minimal genetic content added
|-
|-
|[[STBT5:Composite_haemangioendothelioma_|Composite haemangioendothelioma]]
|[[STBT5:Composite_haemangioendothelioma_|Composite haemangioendothelioma]]
Line 911: Line 913:
|9/21/2025
|9/21/2025
|12/21/2025
|12/21/2025
|PENDING
|COMPLETE
|
|12/12/2025
|
|Katie Schieffer
|
|12/12/2025
|
|No genetic association
|-
|-
|[[STBT5:Inflammatory_leiomyosarcoma|Inflammatory leiomyosarcoma]]
|[[STBT5:Inflammatory_leiomyosarcoma|Inflammatory leiomyosarcoma]]
Line 1,096: Line 1,098:
|9/21/2025
|9/21/2025
|12/21/2025
|12/21/2025
|PENDING
|COMPLETE
|
|12/11/2025
|
|Katie Schieffer
|
|12/11/2025
|
|No genetic association
|-
|-
|-
|-
Line 1,116: Line 1,118:
|9/21/2025
|9/21/2025
|12/21/2025
|12/21/2025
|PENDING
|COMPLETE
|
|12/11/2025
|
|Katie Schieffer
|
|12/11/2025
|
|No genetic association
|-
|-
|[[STBT5:Ectopic_meningioma_and_meningothelial_hamartoma|Ectopic meningioma and meningothelial hamartoma]]
|[[STBT5:Ectopic_meningioma_and_meningothelial_hamartoma|Ectopic meningioma and meningothelial hamartoma]]
Line 1,131: Line 1,133:
|
|
|
|
|
|Consider linking to CNS tumor book
|-
|-
|[[STBT5:Benign_triton_tumour_/_neuromuscular_choristoma|Benign triton tumour / neuromuscular choristoma]]
|[[STBT5:Benign_triton_tumour_/_neuromuscular_choristoma|Benign triton tumour / neuromuscular choristoma]]
Line 1,191: Line 1,193:
|Disease
|Disease
|Katie Schieffer
|Katie Schieffer
|921/2025
|9/21/2025
|12/21/2025
|12/21/2025
|PENDING
|COMPLETE
|
|12/12/2025
|
|Katie Schieffer
|
|12/12/2025
|
|No genetic association
|-
|-
|[[STBT5:Deep_(aggressive)_angiomyxoma|Deep (aggressive) angiomyxoma]]
|[[STBT5:Deep_(aggressive)_angiomyxoma|Deep (aggressive) angiomyxoma]]
Line 1,269: Line 1,271:
|9/11/2025
|9/11/2025
|12/11/2025
|12/11/2025
|PENDING
|COMPLETE
|
|12/29/2026
|Katie Schieffer
|Katie Schieffer
|
|1/7/2026
|
|
|-
|-
|[[STBT5:Haemosiderotic_fibrolipomatous_tumour|Haemosiderotic fibrolipomatous tumour]]
|[[STBT5:Haemosiderotic_fibrolipomatous_tumour|Haemosiderotic fibrolipomatous tumour]]
|Disease
|Disease
|
|Mokhtar Abdelhammed, MD (trainee);
|
Katie Schieffer (mentor)
|
|3/1/2026
|
|6/30/2026
|PENDING
|
|
|
|
Line 1,335: Line 1,338:
|10/13/2025
|10/13/2025
|12/31/2025
|12/31/2025
|PENDING
|COMPLETE
|
|12/24/2025
|Katie Schieffer
|Katie Schieffer
|
|12/24/2025
|
|
|-
|-
Line 1,374: Line 1,377:
|[[STBT5:Desmoplastic_small_round_cell_tumour|Desmoplastic small round cell tumour]]
|[[STBT5:Desmoplastic_small_round_cell_tumour|Desmoplastic small round cell tumour]]
|Disease
|Disease
|
|Maxine Sutcliffe, PhD
|
|1/12/2026
|
|4/12/2026
|
|PENDING
|
|
|
|
Line 1,451: Line 1,454:
|Disease
|Disease
|Sadeem Qdaisat (trainee); Eric McGinnis (mentor)
|Sadeem Qdaisat (trainee); Eric McGinnis (mentor)
|10/1/23
|10/1/2023
|12/9/2025
|12/9/2025
|PENDING
|PENDING
|
|
|
|Katie Schieffer
|
|
|
|
Line 1,527: Line 1,530:
|9/21/2025
|9/21/2025
|12/21/2025
|12/21/2025
|PENDING
|COMPLETE
|
|12/12/2025
|
|Katie Schieffer
|
|12/12/2025
|
|No genetic association
|-
|-
|[[STBT5:Bizarre_parosteal_osteochondromatous_proliferation|Bizarre parosteal osteochondromatous proliferation]]
|[[STBT5:Bizarre_parosteal_osteochondromatous_proliferation|Bizarre parosteal osteochondromatous proliferation]]
Line 1,538: Line 1,541:
|9/21/2025
|9/21/2025
|12/21/2025
|12/21/2025
|PENDING
|COMPLETE
<br />
|12/8/2025
|
|Katie Schieffer
|
|12/8/2025
|
|
|
|-
|-
Line 1,757: Line 1,759:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|-
|-
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Date of Last Editor Review'''
!'''Notes'''
!'''Notes'''
|-
|-
|[[STBT5:Osteosarcoma|Osteosarcoma]]
|[[STBT5:Osteosarcoma|Osteosarcoma]]
|Disease
|Disease
|
|Fang Fang (trainee); Katie Schieffer (mentor)
|
|11/19/2025
|
|2/15/2026
|
|PENDING
|
|
|
|Katie Schieffer
|
|
|
|
Line 2,063: Line 2,065:
|
|
|
|
|
|Refer to lipoma and hibernoma pages in STBT book
|-
|-
|[[STBT5:Leiomyosarcoma_of_bone|Leiomyosarcoma of bone]]
|[[STBT5:Leiomyosarcoma_of_bone|Leiomyosarcoma of bone]]
Line 2,074: Line 2,076:
|
|
|
|
|
|Refer to leiomyosarcoma page in STBT book
|-
|-
|[[STBT5:Undifferentiated_pleomorphic_sarcoma|Undifferentiated pleomorphic sarcoma]]
|[[STBT5:Undifferentiated_pleomorphic_sarcoma|Undifferentiated pleomorphic sarcoma]]
Line 2,118: Line 2,120:
|
|
|
|
|
|Refer to heme book
|-
|-
|-
|-
Line 2,138: Line 2,140:
|
|
|
|
|
|Refer to heme book
|-
|-
|[[STBT5:Erdheim-Chester_disease_|Erdheim-Chester disease]]
|[[STBT5:Erdheim-Chester_disease_|Erdheim-Chester disease]]
Line 2,149: Line 2,151:
|
|
|
|
|
|Refer to heme book
|-
|-
|[[STBT5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
|[[STBT5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
Line 2,160: Line 2,162:
|
|
|
|
|
|Refer to heme book
|-
|-
|
|
Retrieved from "https://test.ccga.io/index.php/STBT5:Volunteer_Assignments_and_Opportunities"